Concepts (206)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hydrogen Sulfide | 13 | 2024 | 141 | 3.240 |
Why?
|
| Quinone Reductases | 3 | 2024 | 23 | 1.020 |
Why?
|
| Leigh Disease | 4 | 2024 | 89 | 0.690 |
Why?
|
| Thiosulfates | 3 | 2015 | 53 | 0.660 |
Why?
|
| Sulfites | 1 | 2015 | 83 | 0.510 |
Why?
|
| Brain Injuries | 2 | 2021 | 2053 | 0.500 |
Why?
|
| Neuroprotective Agents | 3 | 2018 | 957 | 0.500 |
Why?
|
| Heart Arrest | 6 | 2022 | 1514 | 0.500 |
Why?
|
| Reperfusion Injury | 3 | 2018 | 1023 | 0.480 |
Why?
|
| Sulfides | 5 | 2024 | 169 | 0.420 |
Why?
|
| Brain Ischemia | 2 | 2015 | 3049 | 0.360 |
Why?
|
| Parkinson Disease | 2 | 2022 | 2877 | 0.350 |
Why?
|
| Spinal Cord Ischemia | 2 | 2023 | 94 | 0.340 |
Why?
|
| Electron Transport Complex I | 2 | 2021 | 153 | 0.310 |
Why?
|
| NAD | 3 | 2021 | 614 | 0.310 |
Why?
|
| Mitochondria | 6 | 2024 | 3624 | 0.300 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2012 | 894 | 0.280 |
Why?
|
| Acute Lung Injury | 2 | 2022 | 367 | 0.250 |
Why?
|
| Neurons | 3 | 2018 | 9463 | 0.250 |
Why?
|
| Nitric Oxide | 4 | 2022 | 2135 | 0.250 |
Why?
|
| Oxygen | 4 | 2023 | 4227 | 0.220 |
Why?
|
| Mice, Inbred C57BL | 13 | 2023 | 22169 | 0.220 |
Why?
|
| Mice | 23 | 2024 | 81525 | 0.210 |
Why?
|
| Quinones | 1 | 2022 | 78 | 0.210 |
Why?
|
| Friedreich Ataxia | 1 | 2023 | 77 | 0.210 |
Why?
|
| Polycythemia | 1 | 2023 | 124 | 0.200 |
Why?
|
| Paraplegia | 2 | 2023 | 161 | 0.200 |
Why?
|
| Membrane Potential, Mitochondrial | 2 | 2021 | 295 | 0.200 |
Why?
|
| Apoptosis | 4 | 2018 | 9486 | 0.200 |
Why?
|
| Hyperemia | 1 | 2022 | 221 | 0.190 |
Why?
|
| Neurodegenerative Diseases | 3 | 2023 | 1087 | 0.190 |
Why?
|
| Formaldehyde | 2 | 2022 | 358 | 0.190 |
Why?
|
| Hypothermia | 1 | 2022 | 188 | 0.180 |
Why?
|
| Selenium | 1 | 2024 | 417 | 0.180 |
Why?
|
| Mice, Inbred DBA | 1 | 2021 | 621 | 0.170 |
Why?
|
| Brain | 3 | 2021 | 27112 | 0.170 |
Why?
|
| Catalase | 1 | 2020 | 218 | 0.170 |
Why?
|
| Gas Scavengers | 1 | 2019 | 3 | 0.160 |
Why?
|
| Disease Models, Animal | 10 | 2023 | 18252 | 0.160 |
Why?
|
| Aldehyde Oxidoreductases | 1 | 2019 | 87 | 0.160 |
Why?
|
| Mixed Function Oxygenases | 1 | 2020 | 265 | 0.160 |
Why?
|
| Free Radical Scavengers | 1 | 2019 | 211 | 0.150 |
Why?
|
| Tomography | 1 | 2021 | 411 | 0.150 |
Why?
|
| Animals | 24 | 2024 | 168459 | 0.150 |
Why?
|
| Dexmedetomidine | 1 | 2022 | 319 | 0.150 |
Why?
|
| Cell Hypoxia | 2 | 2021 | 656 | 0.150 |
Why?
|
| Hypothermia, Induced | 1 | 2022 | 753 | 0.140 |
Why?
|
| Benzoates | 1 | 2019 | 212 | 0.140 |
Why?
|
| Hyperoxia | 1 | 2019 | 258 | 0.140 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2018 | 517 | 0.140 |
Why?
|
| Anatomy | 1 | 2019 | 126 | 0.140 |
Why?
|
| Cardiopulmonary Resuscitation | 2 | 2022 | 992 | 0.140 |
Why?
|
| Propofol | 1 | 2022 | 603 | 0.140 |
Why?
|
| Urea | 1 | 2019 | 443 | 0.140 |
Why?
|
| Pyrimidinones | 1 | 2019 | 385 | 0.130 |
Why?
|
| Caspase 3 | 2 | 2015 | 731 | 0.130 |
Why?
|
| Protein Engineering | 1 | 2020 | 549 | 0.130 |
Why?
|
| Administration, Inhalation | 5 | 2020 | 1157 | 0.130 |
Why?
|
| Carbon Monoxide | 1 | 2019 | 547 | 0.130 |
Why?
|
| Pyruvate Dehydrogenase Complex | 1 | 2016 | 63 | 0.130 |
Why?
|
| Vasoconstriction | 1 | 2018 | 592 | 0.130 |
Why?
|
| Oxidation-Reduction | 3 | 2019 | 2231 | 0.130 |
Why?
|
| Organoselenium Compounds | 1 | 2015 | 21 | 0.120 |
Why?
|
| Cytoprotection | 1 | 2015 | 200 | 0.120 |
Why?
|
| Anion Transport Proteins | 1 | 2015 | 141 | 0.120 |
Why?
|
| Thiamine | 1 | 2016 | 160 | 0.120 |
Why?
|
| Lactic Acid | 1 | 2020 | 1139 | 0.120 |
Why?
|
| Protective Agents | 1 | 2015 | 150 | 0.110 |
Why?
|
| Oxidative Phosphorylation | 1 | 2016 | 496 | 0.110 |
Why?
|
| Galactosamine | 1 | 2013 | 26 | 0.110 |
Why?
|
| Cystathionine gamma-Lyase | 1 | 2013 | 36 | 0.110 |
Why?
|
| Mice, Knockout | 4 | 2022 | 14414 | 0.110 |
Why?
|
| Cells, Cultured | 3 | 2021 | 18965 | 0.110 |
Why?
|
| Symporters | 1 | 2015 | 363 | 0.100 |
Why?
|
| Carbon | 1 | 2016 | 666 | 0.100 |
Why?
|
| RNA Interference | 1 | 2021 | 2831 | 0.100 |
Why?
|
| Glucose | 2 | 2015 | 4346 | 0.100 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2021 | 8181 | 0.100 |
Why?
|
| Point-of-Care Systems | 1 | 2021 | 1213 | 0.100 |
Why?
|
| Cell Line, Tumor | 4 | 2019 | 16981 | 0.100 |
Why?
|
| Liver Failure, Acute | 1 | 2013 | 181 | 0.100 |
Why?
|
| Memantine | 1 | 2012 | 108 | 0.100 |
Why?
|
| Air Pollution, Indoor | 1 | 2019 | 901 | 0.090 |
Why?
|
| Sciatic Nerve | 1 | 2014 | 617 | 0.090 |
Why?
|
| Models, Chemical | 1 | 2012 | 611 | 0.090 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2012 | 448 | 0.090 |
Why?
|
| Endotoxins | 1 | 2012 | 520 | 0.080 |
Why?
|
| Glutathione | 1 | 2012 | 583 | 0.080 |
Why?
|
| Lipopolysaccharides | 2 | 2014 | 2206 | 0.080 |
Why?
|
| Bacteria | 1 | 2020 | 2199 | 0.080 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2020 | 2151 | 0.080 |
Why?
|
| Analgesics | 1 | 2014 | 1070 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2019 | 10766 | 0.070 |
Why?
|
| Movement Disorders | 1 | 2011 | 459 | 0.070 |
Why?
|
| Drug Design | 1 | 2012 | 1048 | 0.070 |
Why?
|
| Cell Death | 1 | 2012 | 1678 | 0.070 |
Why?
|
| Fluorescent Dyes | 1 | 2015 | 1903 | 0.070 |
Why?
|
| Lung | 3 | 2021 | 10000 | 0.070 |
Why?
|
| Antioxidants | 1 | 2014 | 1668 | 0.070 |
Why?
|
| Gestational Age | 1 | 2015 | 3577 | 0.070 |
Why?
|
| Heart | 1 | 2019 | 4404 | 0.060 |
Why?
|
| Rats | 1 | 2021 | 23742 | 0.060 |
Why?
|
| Environmental Exposure | 1 | 2019 | 4486 | 0.060 |
Why?
|
| Ischemia | 1 | 2012 | 1882 | 0.060 |
Why?
|
| Glutathione Disulfide | 1 | 2023 | 33 | 0.050 |
Why?
|
| HeLa Cells | 2 | 2020 | 3093 | 0.050 |
Why?
|
| Acetaldehyde | 1 | 2022 | 39 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3084 | 0.050 |
Why?
|
| Molecular Structure | 2 | 2019 | 1880 | 0.050 |
Why?
|
| Propylene Glycol | 1 | 2022 | 30 | 0.050 |
Why?
|
| Metronidazole | 1 | 2024 | 232 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3204 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2012 | 1809 | 0.050 |
Why?
|
| Sulfur | 1 | 2023 | 162 | 0.050 |
Why?
|
| Male | 14 | 2023 | 360804 | 0.050 |
Why?
|
| Reactive Oxygen Species | 2 | 2024 | 2141 | 0.050 |
Why?
|
| Aldehydes | 1 | 2022 | 170 | 0.050 |
Why?
|
| Azides | 1 | 2021 | 118 | 0.050 |
Why?
|
| Glycerol | 1 | 2022 | 274 | 0.050 |
Why?
|
| Guanylate Cyclase | 1 | 2022 | 205 | 0.050 |
Why?
|
| Administration, Intranasal | 1 | 2023 | 477 | 0.050 |
Why?
|
| Ataxia | 1 | 2023 | 306 | 0.050 |
Why?
|
| Antidotes | 1 | 2021 | 138 | 0.050 |
Why?
|
| Hydrogen Peroxide | 1 | 2024 | 730 | 0.040 |
Why?
|
| Volatilization | 1 | 2019 | 77 | 0.040 |
Why?
|
| Interleukin-6 | 2 | 2022 | 3208 | 0.040 |
Why?
|
| Methylene Blue | 1 | 2019 | 155 | 0.040 |
Why?
|
| Pyruvic Acid | 1 | 2020 | 204 | 0.040 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2019 | 193 | 0.040 |
Why?
|
| K562 Cells | 1 | 2020 | 642 | 0.040 |
Why?
|
| Solutions | 1 | 2019 | 412 | 0.040 |
Why?
|
| Time Factors | 2 | 2019 | 39967 | 0.040 |
Why?
|
| Transcription Factor RelA | 1 | 2018 | 254 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2022 | 4352 | 0.040 |
Why?
|
| Dissection | 1 | 2019 | 298 | 0.040 |
Why?
|
| bcl-X Protein | 1 | 2018 | 410 | 0.040 |
Why?
|
| Cell Survival | 2 | 2019 | 5791 | 0.030 |
Why?
|
| Electric Impedance | 1 | 2021 | 757 | 0.030 |
Why?
|
| Humans | 14 | 2023 | 761504 | 0.030 |
Why?
|
| Pulmonary Circulation | 1 | 2018 | 737 | 0.030 |
Why?
|
| Cyclization | 1 | 2015 | 59 | 0.030 |
Why?
|
| Behavior, Animal | 2 | 2014 | 1878 | 0.030 |
Why?
|
| Bronchi | 1 | 2018 | 845 | 0.030 |
Why?
|
| Cadaver | 1 | 2019 | 1358 | 0.030 |
Why?
|
| Respiration | 1 | 2021 | 1657 | 0.030 |
Why?
|
| Resuscitation | 1 | 2019 | 673 | 0.030 |
Why?
|
| Cecum | 1 | 2014 | 233 | 0.030 |
Why?
|
| Safety | 1 | 2019 | 1150 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2019 | 3076 | 0.030 |
Why?
|
| Sulfhydryl Compounds | 1 | 2015 | 301 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2019 | 1136 | 0.030 |
Why?
|
| Receptors, Cell Surface | 1 | 2022 | 2822 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2024 | 3113 | 0.030 |
Why?
|
| Macrophages, Peritoneal | 1 | 2013 | 238 | 0.030 |
Why?
|
| Inflammation | 1 | 2012 | 10773 | 0.030 |
Why?
|
| Bone Marrow | 1 | 2022 | 2911 | 0.020 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2013 | 441 | 0.020 |
Why?
|
| Random Allocation | 1 | 2016 | 2395 | 0.020 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2013 | 426 | 0.020 |
Why?
|
| Metabolomics | 1 | 2021 | 1659 | 0.020 |
Why?
|
| Brain Chemistry | 1 | 2015 | 960 | 0.020 |
Why?
|
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 1 | 2011 | 89 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2020 | 3734 | 0.020 |
Why?
|
| Thiophenes | 1 | 2015 | 569 | 0.020 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2013 | 372 | 0.020 |
Why?
|
| Pandemics | 2 | 2021 | 8654 | 0.020 |
Why?
|
| Female | 4 | 2023 | 392644 | 0.020 |
Why?
|
| Hyperalgesia | 1 | 2014 | 531 | 0.020 |
Why?
|
| Pulmonary Artery | 1 | 2018 | 1927 | 0.020 |
Why?
|
| Anemia | 1 | 2019 | 1509 | 0.020 |
Why?
|
| Metabolome | 1 | 2016 | 989 | 0.020 |
Why?
|
| Gene Expression Regulation | 2 | 2018 | 11903 | 0.020 |
Why?
|
| Body Temperature | 1 | 2011 | 781 | 0.020 |
Why?
|
| Massachusetts | 1 | 2020 | 8830 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2022 | 6225 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2013 | 1405 | 0.020 |
Why?
|
| DNA Primers | 1 | 2011 | 2819 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2019 | 10090 | 0.020 |
Why?
|
| Spinal Cord | 1 | 2014 | 1818 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2020 | 3847 | 0.020 |
Why?
|
| Hepatocytes | 1 | 2013 | 1233 | 0.020 |
Why?
|
| Proteome | 1 | 2016 | 1862 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 9539 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2014 | 2490 | 0.020 |
Why?
|
| Microglia | 1 | 2014 | 1361 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2013 | 2455 | 0.010 |
Why?
|
| Signal Transduction | 2 | 2018 | 23445 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2019 | 10445 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2011 | 5035 | 0.010 |
Why?
|
| Hippocampus | 1 | 2016 | 3766 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2012 | 6216 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2020 | 64680 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2013 | 8320 | 0.010 |
Why?
|
| Cell Line | 1 | 2016 | 15601 | 0.010 |
Why?
|
| Survival Rate | 1 | 2016 | 12725 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2011 | 6075 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 9420 | 0.010 |
Why?
|
| Base Sequence | 1 | 2011 | 12441 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2016 | 5777 | 0.010 |
Why?
|
| Cytokines | 1 | 2014 | 7396 | 0.010 |
Why?
|
| Mutation | 1 | 2024 | 30052 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2015 | 8481 | 0.010 |
Why?
|
| Pregnancy | 1 | 2020 | 29874 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2016 | 22176 | 0.010 |
Why?
|
| Liver | 1 | 2013 | 7529 | 0.010 |
Why?
|
| Models, Biological | 1 | 2013 | 9469 | 0.010 |
Why?
|
Concepts
(206)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(35)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_